Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:110-115
doi: 10.1161/01.CIR.0000077519.18416.43
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huikuri, H. V.
Right arrow Articles by Myerburg, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huikuri, H. V.
Right arrow Articles by Myerburg, R. J.
Related Collections
Right arrow Electrocardiology
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2003;108:110.)
© 2003 American Heart Association, Inc.


Brief Review: Current Perspective

Prediction of Sudden Cardiac Death

Appraisal of the Studies and Methods Assessing the Risk of Sudden Arrhythmic Death

Heikki V. Huikuri, MD; Timo H. Mäkikallio, MD; M. J. Pekka Raatikainen, MD; Juha Perkiömäki, MD; Agustin Castellanos, MD; Robert J. Myerburg, MD

From the Division of Cardiology, Department of Internal Medicine, University of Oulu, Finland (H.V.H., T.H.M., M.J.P.R., J.P.), and Division of Cardiology, University of Miami School of Medicine, Miami, Fla (A.C., R.J.M.).

Correspondence to Heikki V. Huikuri, MD, Division of Cardiology, University of Oulu, Kajaanintie 50, 90220, Oulu, Finland. E-mail heikki.huikuri@oulu.fi


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Since the recognition of the high incidence of cardiac arrest as the mechanism of sudden cardiac death (SCD), medical scientists and clinicians have sought methods to predict and prevent these events. Significant progress has already been made in the prediction and prevention of life-threatening arrhythmias during the last decade. This progress is highlighted by the outcomes of 4 recently published randomized studies demonstrating that the implantable cardioverter defibrillator (ICD) provides a mortality benefit compared with conventional drug therapy in highly specific subsets of patients.1–4 In parallel with intervention studies, several observational studies and reports have raised an optimistic notion that arrhythmic death can be predicted by methods potentially useful for widespread screening programs.5–10

Despite the evidence-based data and practical recommendations for indications of ICD therapy,11 utilization of this therapy has not been uniformly implemented worldwide, and screening of patients at potential high risk for arrhythmic death has not become a routine clinical practice. In addition to economic and educational factors, this may be due to methodological problems in the designs of a number of the completed observational and randomized intervention studies that confound the interpretation of the results and general application of the procedures. In this report, we analyze the problems of predicting arrhythmic deaths and the advantages and limitations of the various methods and studies, and we evaluate the need for new and better studies and methods of risk stratification.

Study Designs

Three types of clinical research designs have been used to estimate the efficacy of interventions and the accuracy of . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
EuropaceHome page
H. V. Huikuri
Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death
Europace, December 1, 2009; 11(12): 1574 - 1574.
[Full Text] [PDF]


Home page
Phil Trans R Soc AHome page
H. V Huikuri, J. S Perkiomaki, R. Maestri, and G. D. Pinna
Clinical impact of evaluation of cardiovascular control by novel methods of heart rate dynamics
Phil Trans R Soc A, April 13, 2009; 367(1892): 1223 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. V. Huikuri, M.J. P. Raatikainen, R. Moerch-Joergensen, J. Hartikainen, V. Virtanen, J. Boland, O. Anttonen, N. Hoest, L. V.A. Boersma, E. S. Platou, et al.
Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction
Eur. Heart J., March 2, 2009; 30(6): 689 - 698.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. V. Huikuri, K. Kervinen, M. Niemela, K. Ylitalo, M. Saily, P. Koistinen, E.-R. Savolainen, H. Ukkonen, M. Pietila, J. K.E. Airaksinen, et al.
Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction
Eur. Heart J., November 2, 2008; 29(22): 2723 - 2732.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. U. Viola, L. M. James, S. N. Archer, and D.-J. Dijk
PER3 polymorphism and cardiac autonomic control: effects of sleep debt and circadian phase
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2156 - H2163.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
M. J. Silka and Y. Bar-Cohen
Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?: Patients With Congenital Heart Disease and a Systemic Ventricular Ejection Fraction Less Than 30% Should Undergo Prophylactic Implantation of an Implantable Cardioverter Defibrillator
Circ Arrhythm Electrophysiol, October 1, 2008; 1(4): 298 - 306.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. L. del Rio, P. I. McConnell, M. Kukielka, R. Dzwonczyk, B. D. Clymer, M. B. Howie, and G. E. Billman
Electrotonic remodeling following myocardial infarction in dogs susceptible and resistant to sudden cardiac death
J Appl Physiol, February 1, 2008; 104(2): 386 - 393.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Fischer, R. Dechend, A. Gapelyuk, E. Shagdarsuren, K. Gruner, A. Gruner, P. Gratze, F. Qadri, M. Wellner, A. Fiebeler, et al.
Angiotensin II-induced sudden arrhythmic death and electrical remodeling
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1242 - H1253.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. G. Assomull, S. K. Prasad, J. Lyne, G. Smith, E. D. Burman, M. Khan, M. N. Sheppard, P. A. Poole-Wilson, and D. J. Pennell
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
J. Am. Coll. Cardiol., November 21, 2006; 48(10): 1977 - 1985.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. S. Kaikkonen, M.-L. Kortelainen, E. Linna, and H. V. Huikuri
Family History and the Risk of Sudden Cardiac Death as a Manifestation of an Acute Coronary Event
Circulation, October 3, 2006; 114(14): 1462 - 1467.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1064 - 1108.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D. P. Zipes, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
Eur. Heart J., September 1, 2006; 27(17): 2099 - 2140.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. A. Cesario and G. W. Dec
Implantable Cardioverter- Defibrillator Therapy in Clinical Practice
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1507 - 1517.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Myerburg and A. Castellanos
Clinical Research Designs and Implantable Defibrillator Indications: Spend in the Beginning or Pay at the End
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 108 - 111.
[Full Text] [PDF]


Home page
ChestHome page
E. G. Manios, E. M. Kallergis, E. M. Kanoupakis, H. E. Mavrakis, D. C. Kambouraki, D. A. Arfanakis, and P. E. Vardas
Amino-Terminal Pro-Brain Natriuretic Peptide Predicts Ventricular Arrhythmogenesis in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillators
Chest, October 1, 2005; 128(4): 2604 - 2610.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Guzzetti, E. Borroni, P. E. Garbelli, E. Ceriani, P. D. Bella, N. Montano, C. Cogliati, V. K. Somers, A. Mallani, and A. Porta
Symbolic Dynamics of Heart Rate Variability: A Probe to Investigate Cardiac Autonomic Modulation
Circulation, July 26, 2005; 112(4): 465 - 470.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. H. Makikallio, P. Barthel, R. Schneider, A. Bauer, J. M. Tapanainen, M. P. Tulppo, G. Schmidt, and H. V. Huikuri
Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era
Eur. Heart J., April 2, 2005; 26(8): 762 - 769.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. Lombardi
Sympathetic activation and sub-clinical inflammation: a new combination to identify high risk subjects
Eur. Heart J., March 1, 2004; 25(5): 359 - 360.
[Full Text] [PDF]